State of Alaska Department of Revenue reduced its holdings in DaVita Inc. (NYSE:DVA – Free Report) by 4.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,144 shares of the company’s stock after selling 215 shares during the quarter. State of Alaska Department of Revenue’s holdings in DaVita were worth $769,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Transcendent Capital Group LLC bought a new stake in DaVita in the third quarter valued at $25,000. Blue Trust Inc. boosted its stake in shares of DaVita by 56.4% during the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after purchasing an additional 119 shares in the last quarter. Quarry LP purchased a new position in shares of DaVita during the third quarter valued at about $60,000. Versant Capital Management Inc raised its stake in DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after buying an additional 169 shares in the last quarter. Finally, Huntington National Bank lifted its holdings in DaVita by 39.1% in the third quarter. Huntington National Bank now owns 768 shares of the company’s stock worth $126,000 after buying an additional 216 shares during the period. 90.12% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Barclays increased their target price on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $161.80.
DaVita Price Performance
Shares of DVA opened at $156.95 on Friday. DaVita Inc. has a fifty-two week low of $118.56 and a fifty-two week high of $179.60. The firm’s 50-day simple moving average is $161.41 and its two-hundred day simple moving average is $157.37. The stock has a market cap of $12.87 billion, a PE ratio of 16.93, a price-to-earnings-growth ratio of 0.84 and a beta of 0.94. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37.
DaVita (NYSE:DVA – Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 88.18% and a net margin of 6.53%. Analysts anticipate that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.
About DaVita
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading
- Five stocks we like better than DaVita
- Profitably Trade Stocks at 52-Week Highs
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- How to Plot Fibonacci Price Inflection Levels
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- 3 Warren Buffett Stocks to Buy Now
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.